Sr. No.	Received from	Pending at the end of last month	Received	Resolved*	Total Pending #	Pending complaints >3months	Average Resolution time^ (in days)
1	Directly from Investors	0	0	0	0	0	0
2	SEBI (SCORES)	0	0	0	0	0	0
3	Other Sources (if any)	0	0	0	0	0	0
	Grand Total	0	0	0	0	0	0

Sr. No.	Month	Carried forward from previous month	Received	Resolved*	Pending#
1	Jun, 2026	0	0	0	0
2	Jul, 2026	0	0	0	0
3	Aug, 2026	0	0	0	0
	Grand Total	0	0	0	0

Sr. No.	Fin. Year	Received	Resolved*
1	2022-23	1	1
2	2023-24	0	0
3	2024-25	0	0
4	2025-26	1	1
	Grand Total	2	2

Top Pharma Companies in India by Market Cap

BSE Sensex 75550.42 1090.89 (1.47%)

Filter

Top Pharma Companies in India as on Nov-2026 | 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks

Filter

Expand company details	Company Name	DeciZen	Market cap (Rs. Cr.)	CMP (Change %)	Latest P/E	Latest P/BV	5Y Sales Gr.(%)	5Y Profit Gr.(%)	More company information
91	Unichem Laboratories Ltd.	Q V PT	3,404 Small Cap	494 (2.18%)	11.17	1.24	12.26	24.44	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
92	Lupin Ltd.	Q V PT	91,870 Mid Cap	2,027.70 (0.93%)	16.62	3.86	13.02	32.37	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
93	Gland Pharma Ltd.	Q V PT	51,112 Mid Cap	3,069 (-0.92%)	45.28	4.81	13.18	0.09	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
94	Zydus Lifesciences Ltd.	Q V PT	1,24,089 Mid Cap	1,239.05 (-0.40%)	27.5	4.6	13.52	14.72	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
95	Ajanta Pharma Ltd.	Q V+ PT	43,891 Mid Cap	3,425.80 (-2.47%)	34.76	9.03	13.54	10.92	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
96	Blue Jet Healthcare Ltd.	Q V PT	9,547 Small Cap	501.20 (-0.63%)	40.64	4.27	13.68	9.45	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
97	Kwality Pharmaceuticals Ltd.	Q V+ PT	3,604 Small Cap	3,511.15 (1.08%)	44.47	10.11	13.94	34.90	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
98	Anthem Biosciences Ltd.	Q V PT	46,685 Mid Cap	834.05 (0.68%)	81.06	14.92	14.00	16.46	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
99	NGL Fine-Chem Ltd.	Q V PT	1,576 Small Cap	2,557.20 (0.24%)	27.55	4.53	14.19	-3.22	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
100	GPT Healthcare Ltd.	Q V PT	1,089 Small Cap	133.30 (0.45%)	23.04	3.86	14.25	6.47	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
101	Vimta Labs Ltd.	Q V+ PT	2,167 Small Cap	488.30 (0.71%)	26.97	4.41	14.27	28.52	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
102	Natco Pharma Ltd.	Q V+ PT	15,350 Small Cap	784.75 (0.29%)	13.41	1.45	14.72	28.08	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
103	Apollo Hospitals Enterprise Ltd.	Q V+ PT	1,20,779 Large Cap	8,430.30 (0.36%)	76.88	11.71	14.92	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
104	Caplin Point Laboratories Ltd.	Q V PT	17,672 Small Cap	2,342.70 (0.77%)	26.56	4.81	15.56	20.24	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
105	Windlas Biotech Ltd.	Q V PT	1,810 Small Cap	867.15 (-1.15%)	27.24	3.52	16.15	12.78	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
106	Marksans Pharma Ltd.	Q V+ PT	13,896 Small Cap	310 (1.09%)	26.89	4.37	16.48	7.89	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
107	Neuland Laboratories Ltd.	Q V+ PT	25,276 Small Cap	19,550.15 (-0.77%)	50.78	12.51	16.64	37.55	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
108	Vijaya Diagnostic Centre Ltd.	Q V+ PT	14,906 Small Cap	1,438.55 (-0.60%)	79.51	14.8	16.66	14.99	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
109	Suraksha Diagnostic Ltd.	Q V PT	1,653 Small Cap	325 (2.39%)	46.18	6.44	17.26	-44.22	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
110	Healthcare Global Enterprises Ltd.	Q V+ PT	8,731 Small Cap	581.55 (-0.56%)	522.51	5.42	17.43	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
111	Cohance Lifesciences Ltd.	Q V+ PT	17,005 Small Cap	449.45 (1.12%)	160.07	4.42	17.57	-18.37	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
112	Fortis Healthcare Ltd.	Q V+ PT	58,117 Mid Cap	766.90 (-0.38%)	55.46	5.72	17.76	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
113	Kovai Medical Center & Hospital Ltd.	Q V PT	6,356 Small Cap	5,734.45 (-1.27%)	24.8	4.58	18.09	25.97	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
114	Mankind Pharma Ltd.	Q V PT	1,02,797 Mid Cap	2,510.55 (0.88%)	45.84	5.85	18.10	8.40	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
115	Poly Medicure Ltd.	Q V PT	14,676 Small Cap	1,463.95 (1.11%)	46.58	4.61	18.98	16.92	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
116	Sigachi Industries Ltd.	Q V+ PT	1,009 Small Cap	25.02 (-5.23%)	40.6	1.87	19.91	-146.99	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
117	Viyash Scientific Ltd.	Q V PT	9,653 Small Cap	219.30 (0.37%)	56.39	3.43	20.23	2.33	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
118	Eris Lifesciences Ltd.	Q V+ PT	16,088 Small Cap	1,175 (1.33%)	22.74	3.88	20.89	11.86	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
119	Rainbow Childrens Medicare Ltd.	Q V PT	12,366 Small Cap	1,230.55 (1.07%)	42.32	7.21	21.24	43.99	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
120	Syncom Formulations (India) Ltd.	Q V+ PT	1,810 Small Cap	19.35 (0.52%)	21.16	4.11	21.49	39.14	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
Prev 1 2 3 4 5 Next

Screens:

AlphaCases Top Rated Stocks Best Nifty Stocks Best Nifty Next Stocks Best Nifty 500 Stocks Best SmallCap Stocks Top BFSI Stocks

Pharma - Today's Top Gainers

Company Name	CMP	Price Change(%)
Narayana Hrudayalay.	1,840.30	7.01%
Advanced Enzyme Tech	279.60	6.33%
Indegene	622.10	5.86%
Themis Medicare	99.84	5.09%
Max Healthcare Inst.	900	4.65%

Pharma - Today's Top Losers

Company Name	CMP	Price Change(%)
Sigachi Industries	25.02	-5.23%
Morepen Laboratories	108.05	-4.97%
Concord Biotech	1,188	-4.60%
Bliss GVS Pharma	623	-3.92%
Artemis MedicareServ	281.55	-3.64%

News about Top Pharma Companies in India

Nov, 2026

RainbowChildrenS Med - Quaterly Results

A fair growth of 19.22% in the revenue at Rs. 4869.91 millions was reported in the September 2026 quarter as compared to Rs. 4084.96 millions during year-ago period.A meek growth of 2.63% was reported for the quarter ended September 2026 to Rs. 750.93 millions from Rs. 731.67 millions.Operating Profit saw a handsome growth to 1595.88 millions from 1488.91 millions in the quarter ended September 2026.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202609	202509	% Var	202609	202509	% Var	202603	202503	% Var
Sales	4869.91	4084.96	19.22	8975.38	7432.44	20.76	15456.60	14545.06	6.27
Other Income	80.92	81.73	-0.99	208.49	274.58	-24.07	434.54	489.49	-11.23
PBIDT	1595.88	1488.91	7.18	2870.04	2676.97	7.21	5433.11	5234.23	3.80
Interest	199.14	173.09	15.05	391.63	347.02	12.86	713.96	695.94	2.59
PBDT	1396.74	1315.82	6.15	2478.41	2329.95	6.37	4703.76	4538.29	3.65
Depreciation	398.09	331.82	19.97	774.35	657.75	17.73	1362.61	1317.48	3.43
PBT	998.65	984.00	1.49	1704.06	1672.20	1.91	3341.15	3220.81	3.74
TAX	247.72	252.33	-1.83	426.07	423.33	0.65	840.99	844.98	-0.47
Deferred Tax	-57.47	-27.87	106.21	-68.71	-22.06	211.47	-73.38	-31.54	132.66
PAT	750.93	731.67	2.63	1277.99	1248.87	2.33	2500.16	2375.83	5.23
Equity	1015.66	1015.59	0.01	1015.66	1015.59	0.01	1015.59	1015.52	0.01
PBIDTM(%)	32.77	36.45	-10.09	31.98	36.02	-11.22	35.15	35.99	-2.32

Nov, 2026

Sigachi Industries - Quaterly Results

The sales figure stood at Rs. 1134.85 millions for the September 2026 quarter. The mentioned figure indicates a growth of about 35.19% as compared to Rs. 839.43 millions during the year-ago period.A slender decline of -23.68% was recorded to Rs. 89.77 millions from Rs. 117.62 millions in the corresponding previous quarter.Operating profit surged to 172.97 millions from the corresponding previous quarter of 91.58 millions.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202609	202509	% Var	202609	202509	% Var	202603	202503	% Var
Sales	1134.85	839.43	35.19	2117.61	1949.20	8.64	3790.42	4078.33	-7.06
Other Income	2.19	24.92	-91.21	6.62	64.33	-89.71	82.28	200.77	-59.02
PBIDT	172.97	91.58	88.87	308.98	370.60	-16.63	582.27	943.38	-38.28
Interest	31.63	25.27	25.17	53.49	46.74	14.44	101.34	106.57	-4.91
PBDT	141.34	112.87	25.22	255.49	-839.64	-130.43	-701.20	836.81	-183.79
Depreciation	36.21	33.13	9.30	72.42	72.63	-0.29	144.31	129.22	11.68
PBT	105.13	79.74	31.84	183.07	-912.27	-120.07	-845.51	707.59	-219.49
TAX	15.36	-37.88	-140.55	28.22	-38.45	-173.39	-50.05	230.92	-121.67
Deferred Tax	-8.40	-37.88	-77.82	-16.80	-38.45	-56.31	-54.30	105.18	-151.63
PAT	89.77	117.62	-23.68	154.85	-873.82	-117.72	-795.46	476.67	-266.88
Equity	382.12	382.12	0.00	382.12	382.12	0.00	382.12	382.12	0.00
PBIDTM(%)	15.24	10.91	39.71	14.59	19.01	-23.26	15.36	23.13	-33.59

Oct, 2026

Vimta Labs - Quaterly Results

A fair growth of 9.95% in the revenue at Rs. 1119.83 millions was reported in the September 2026 quarter as compared to Rs. 1018.48 millions during year-ago period.A meek growth of 3.48% was reported for the quarter ended September 2026 to Rs. 206.14 millions from Rs. 199.20 millions.Operating profit surged to 407.78 millions from the corresponding previous quarter of 368.88 millions.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202609	202509	% Var	202609	202509	% Var	202603	202503	% Var
Sales	1119.83	1018.48	9.95	2210.57	1994.12	10.85	4072.90	3439.82	18.40
Other Income	29.04	26.58	9.26	67.16	44.07	52.39	89.89	42.40	112.00
PBIDT	407.78	368.88	10.55	819.01	723.27	13.24	1505.08	1261.89	19.27
Interest	3.85	3.74	2.94	6.22	6.89	-9.72	11.67	19.00	-38.58
PBDT	403.93	365.14	10.62	812.79	716.38	13.46	1477.25	1242.89	18.86
Depreciation	128.68	102.40	25.66	254.16	201.02	26.44	437.72	352.89	24.04
PBT	275.25	262.74	4.76	558.63	515.36	8.40	1039.53	890.00	16.80
TAX	69.11	63.54	8.77	142.07	127.22	11.67	264.41	222.45	18.86
Deferred Tax	1.58	-3.17	-149.84	16.02	-7.23	-321.58	-1.07	12.66	-108.45
PAT	206.14	199.20	3.48	416.56	388.14	7.32	775.12	667.55	16.11
Equity	89.40	89.08	0.36	89.40	89.08	0.36	89.34	44.47	100.90
PBIDTM(%)	36.41	36.22	0.54	37.05	36.27	2.15	36.95	36.68	0.73

Oct, 2026

Ajanta Pharma - Quaterly Results

The sales moved up 41.37% to Rs. 17250.70 millions for the September 2026 quarter as compared to Rs. 12202.40 millions during the year-ago period.Profit after tax for the quarter ended September 2026 reported a huge growth of 52.24% to Rs. 3798.90 millions from Rs. 2495.30 millions.Operating Profit saw a handsome growth to 5697.10 millions from 3646.20 millions in the quarter ended September 2026.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202609	202509	% Var	202609	202509	% Var	202603	202503	% Var
Sales	17250.70	12202.40	41.37	32137.40	24288.00	32.32	48459.20	43220.40	12.12
Other Income	526.20	750.30	-29.87	1234.40	1156.60	6.73	2044.00	1198.70	70.52
PBIDT	5697.10	3646.20	56.25	10372.30	7346.50	41.19	14023.90	13245.90	5.87
Interest	7.90	7.30	8.22	15.50	14.60	6.16	25.90	46.00	-43.70
PBDT	5689.20	3638.90	56.34	10356.80	7331.90	41.26	13998.00	13199.90	6.05
Depreciation	463.00	419.20	10.45	896.10	822.30	8.97	1687.70	1399.30	20.61
PBT	5226.20	3219.70	62.32	9460.70	6509.60	45.33	12310.30	11800.60	4.32
TAX	1427.30	724.40	97.03	2507.10	1464.60	71.18	2842.10	2631.70	7.99
Deferred Tax	-158.10	64.70	-344.36	-94.60	97.60	-196.93	76.00	51.40	47.86
PAT	3798.90	2495.30	52.24	6953.60	5045.00	37.83	9468.20	9168.90	3.26
Equity	250.70	250.70	0.00	250.70	250.70	0.00	250.70	250.70	0.00
PBIDTM(%)	33.03	29.88	10.52	32.27	30.25	6.70	28.94	30.65	-5.57

Oct, 2026

Vimta Labs informs about unaudited financial results

Vimta Labs has enclosed unaudited Financial Results as per Regulation 33 of the SEBI (LODR) Regulations, 2015 for the 02nd Quarter and Half Year ended 30th September 2026 along with Limited Review Report. The said Financial Results were duly reviewed and recommended by the Audit Committee and approved by the Board of Directors of the Company, at their respective meetings held today. Further to earlier intimation dated 6th May 2026 regarding the proposed incorporation of a wholly owned subsidiary in the USA, the Board of Directors of the Company, at its meeting held today, took note of the incorporation of Vimta Labs LLC as a wholly owned subsidiary of the Company. The meeting of the Board of Directors of the Company commenced at 10:30 AM and concluded at 01:00 PM.

The above information is a part of company’s filings submitted to BSE.

Oct, 2026

NATCO Pharma informs about disclosure

NATCO Pharma has informed that the exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Venkaiah Chowdary Nannapaneni.

The above information is a part of company’s filings submitted to BSE.

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Rank	Company	Market Capitalization 2026 (INR crores)
1	Take Ltd.	159 Crore
2	Suven Life Sciences Ltd.	7,293 Crore
3	Aster DM Quality Care Ltd.	59,570 Crore
4	3B Blackbio Dx Ltd.	1,113 Crore
5	Aurobindo Pharma Ltd.	96,537 Crore
6	Ind-Swift Laboratories Ltd.	3,246 Crore
7	Solara Active Pharma Sciences Ltd.	3,055 Crore
8	Hikal Ltd.	2,601 Crore
9	Fabtech Technologies Ltd.	547 Crore
10	Sanofi Consumer Healthcare India Ltd.	7,911 Crore

Do you know? Asking 3 Right Questions minimizes the RISK of Stock Investing To Know

Right Stock | Right Price | Right Allocation

Find best stocks to buy now Find best pharma stocks to buy now

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the Nifty Pharma companies index are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	ROE
Abbott India Ltd. (M)	Very Good	25,731	54,384	33.68	10.51	23.07	34.24
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,598	1,76,306	83.01	9.60	33.08	29.04
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,390	65,137	36.23	5.94	12.08	27.89
Lupin Ltd. (M)	Somewhat Good	2,028	91,870	16.62	3.86	9.20	26.43
Ajanta Pharma Ltd. (M)	Very Good	3,426	43,891	34.76	9.03	23.33	25.35

Based on the past year's gain, the best performing stocks are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	Yearly gain (%)
Laurus Labs Ltd. (M)	Very Good	2,380	1,29,243	147
Sai Life Sciences Ltd. (S)	Somewhat Good	1,550	33,139	69.37
Gland Pharma Ltd. (M)	Very Good	3,069	51,112	61.94
Aurobindo Pharma Ltd. (M)	Very Good	1,668	96,537	52.18
Ipca Laboratories Ltd. (M)	Very Good	1,966	48,907	49.58
				View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Sales Growth (%)
Sai Life Sciences Ltd. (S)	Somewhat Good	1,550	33,139	91.61	12.98	47.25	23.61
Mankind Pharma Ltd. (M)	Very Good	2,511	1,02,797	45.84	5.85	24.28	18.10
Ajanta Pharma Ltd. (M)	Very Good	3,426	43,891	34.76	9.03	23.33	13.54
Zydus Lifesciences Ltd. (M)	Very Good	1,239	1,24,089	27.50	4.60	15.32	13.52
Gland Pharma Ltd. (M)	Very Good	3,069	51,112	45.28	4.81	23.17	13.18

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Profit Growth (%)
Sai Life Sciences Ltd. (S)	Somewhat Good	1,550	33,139	91.61	12.98	47.25	39.96
Lupin Ltd. (M)	Somewhat Good	2,028	91,870	16.62	3.86	9.20	32.37
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,390	65,137	36.23	5.94	12.08	22.19
Abbott India Ltd. (M)	Very Good	25,731	54,384	33.68	10.51	23.07	17.33
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,357	1,12,699	40.25	2.90	18.79	15.75

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Current Complaints

*Inclusive of complaints of previous months resolved in the current month. #Inclusive of complaints pending as on the last day of the month.

*Inclusive of complaints of previous months resolved in the current month. #Inclusive of complaints pending as on the last day of the year.

Top Pharma Companies in India by Market Cap

News about Top Pharma Companies in India

RainbowChildrenS Med - Quaterly Results

Sigachi Industries - Quaterly Results

Vimta Labs - Quaterly Results

Ajanta Pharma - Quaterly Results

Vimta Labs informs about unaudited financial results

NATCO Pharma informs about disclosure

Publicly traded pharmaceuticals

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

How to select the top Nifty Pharma stocks based on RoE?

What are the best-performing stocks in the Nifty Pharma index?

Which Nifty Pharma stocks have the highest revenue growth in the past five years?

Which Nifty Pharma stocks had the highest profit growth in the past five years ?